Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103681519 | 10368151 | 9 | F | 20150617 | 20160707 | 20140807 | 20160713 | EXP | PHHY2014IT096235 | NOVARTIS | 44.08 | YR | F | Y | 65.00000 | KG | 20160713 | OT | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103681519 | 10368151 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | 22068 | 600 | MG | CAPSULE | QD | ||||||
103681519 | 10368151 | 2 | C | AMILORIDE W/HYDROCHLOROTHIAZIDE | AMLODIPINEHYDROCHLOROTHIAZIDEOLMESARTAN | 1 | Unknown | 50 + 50 MG PER DAY | 0 | 50 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
103681519 | 10368151 | 1 | Chronic myeloid leukaemia |
103681519 | 10368151 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
103681519 | 10368151 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
103681519 | 10368151 | Abdominal pain | |
103681519 | 10368151 | Diverticulitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
103681519 | 10368151 | 1 | 20101130 | 0 | ||
103681519 | 10368151 | 2 | 20101116 | 0 |